Squamous Cell Lung Carcinoma with ROS1CD74-ROS1 Fusion 76% Rearrangement and PDL-1 50% TPS: A Case Report

In the Philippines, lung cancer is the 4th most frequent cancer among women. Adenocarcinoma is the predominant histology type among females, worldwide. Squamous cell lung carcinoma is most associated with familial clustering of cancer, particularly among women. ROS1 rearrangements are extremely rare in squamous cell lung carcinoma (less than 0.2% of cases). Squamous cell lung cancer typically has higher PD-L1 expression than adenocarcinoma. Most ROS1-positive tumors do not express PD-L1 and have a low tumor mutational burden. The correlation between ROS1 rearrangements and PD-L1 overexpression is the least investigated among the druggable translocations in NSCLC. Here is presented a 69-year-old female, nonsmoker with poorly differentiated squamous cell lung carcinoma presenting a massive right upper lung mass adherent to the middle mediastinal structures, with pleural effusion, with ROS1CD74-ROS1 fusion 76% rearrangement and PDL-1 50% TPS, with several co-morbidities and a strong family history of cancer.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-03-15
DOI
https://doi.org/10.5281/zenodo.15015911
Primary Topic
Lung Cancer Treatments and Mutations
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Squamous Cell Lung Carcinoma with ROS1CD74-ROS1 Fusion 76% Rearrangement and PDL-1 50% TPS: A Case Report

Zenodo (CERN European Organization for Nuclear Research)
Lung Cancer Treatments and Mutations
article

Squamous Cell Lung Carcinoma with ROS1CD74-ROS1 Fusion 76% Rearrangement and PDL-1 50% TPS: A Case Report

article en

Abstract

In the Philippines, lung cancer is the 4th most frequent cancer among women. Adenocarcinoma is the predominant histology type among females, worldwide. Squamous cell lung carcinoma is most associated with familial clustering of cancer, particularly among women. ROS1 rearrangements are extremely rare in squamous cell lung carcinoma (less than 0.2% of cases). Squamous cell lung cancer typically has higher PD-L1 expression than adenocarcinoma. Most ROS1-positive tumors do not express PD-L1 and have a low tumor mutational burden. The correlation between ROS1 rearrangements and PD-L1 overexpression is the least investigated among the druggable translocations in NSCLC. Here is presented a 69-year-old female, nonsmoker with poorly differentiated squamous cell lung carcinoma presenting a massive right upper lung mass adherent to the middle mediastinal structures, with pleural effusion, with ROS1CD74-ROS1 fusion 76% rearrangement and PDL-1 50% TPS, with several co-morbidities and a strong family history of cancer.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 36%
Lung Cancer Treatments and Mutations
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Squamous Cell Lung Carcinoma with ROS1CD74-ROS1 Fusion 76% Rearrangement and PDL-1 50% TPS: A Case Report · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS